Today's world of B2B sales has many moving parts because a sales team must deal with the varying perspectives of contacts, influencers and stakeholders who provide input on the buying decision.
One of the chief complaints about government is that it's often behind the eight ball when it comes to discerning macro trends, putting consumers, businesses and the broader economy at risk.
When Protein Sciences first launched Flublok — the only egg- and preservative-free flu vaccine on the market — it expected the product to be major player in a global influenza vaccine market.
Q&A talks with Bijan Almassian, president and CEO of CaroGen, a Farmington-based bioscience company developing a hepatitis B virus (HBV) immunotherapy, using replication-proficient virus-like vesicles (VLVs) technology.